Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Pramlintide approval date?
How to apply for vascepa's patient assistance?
Guselkumab loss of exclusitivy?
Quartette side effects?
When will there be a generic loreev available?

How does cosentyx alter senior's immune response?

See the DrugPatentWatch profile for cosentyx

Cosentyx (secukinumab) and the immune system in older adults

What Cosentyx does How it changes the immune system What that means for a senior patient
Blocks IL‑17A – a cytokine produced mainly by Th17 cells 1. Less IL‑17A in circulation → ↓ recruitment of neutrophils and other inflammatory cells to skin and joints.
2. Reduced “inflammatory cascade” – cytokines such as IL‑1β, TNF‑α, and IL‑6 that amplify disease are also dampened.		 1. Lower disease activity – psoriasis, psoriatic arthritis, and ankylosing spondylitis flare‑ups become less severe and less frequent.
2. Weakened mucosal and systemic defenses – IL‑17A is a key player in guarding against fungal (e.g., Candida), bacterial, and viral infections, especially at mucosal surfaces.

Why seniors are a special population

  1. Immunosenescence – the immune system naturally weakens with age.
  2. Comorbidities – heart disease, diabetes, chronic kidney or lung disease, and medication interactions are common.
  3. Vaccination status – older adults often have lower vaccine responses.

Because Cosentyx suppresses a specific part of the immune system, seniors may be at a slightly higher risk for:

  • Upper respiratory infections (especially viral).
  • Fungal infections (oral thrush, skin candidiasis).
  • Bacterial infections such as sinusitis or skin abscesses, though the risk is generally lower than with broad immunosuppressants.
  • Potential interference with vaccine‑induced immunity – particularly for vaccines that rely on Th17 responses (e.g., some flu or pneumococcal vaccines).

In practice, the overall safety profile of secukinumab in seniors is comparable to that in younger adults, but clinicians usually:

  • Screen for latent tuberculosis (TB) and other infections before starting therapy.
  • Monitor for new or worsening infections and advise patients to seek care promptly.
  • Adjust dosing if the patient has kidney or liver impairment.

How a senior’s immune response changes on Cosentyx

  1. Inflammatory response – markedly reduced, leading to calmer skin and joints.
  2. Neutrophil recruitment – fewer neutrophils are directed to sites of inflammation, so the classic “red‑hot‑warm‑swollen” signs become milder.
  3. Mucosal immunity – decreased IL‑17A can impair barrier defenses, making mucosal surfaces (mouth, throat, gut) more susceptible to infection.
  4. Adaptive immunity – overall antibody production is largely unaffected, but cellular memory against certain pathogens may be slightly blunted.

Practical take‑aways for seniors

Tip Why it matters
Stay up to date on vaccinations (flu, pneumococcal, shingles) before starting Cosentyx. Helps build the strongest possible immunity while IL‑17A is suppressed.
Report infections early – even mild symptoms of cough, sore throat, or oral redness should be evaluated. Prompt treatment reduces the chance of complications.
Maintain oral hygiene – regular brushing and tongue cleaning to reduce Candida colonization. Reduces the risk of oral thrush.
Monitor for injection site reactions – mild redness or swelling is common; severe pain or swelling warrants medical review. Helps differentiate normal reactions from infection.
Regular follow‑ups with your rheumatologist or dermatologist. Adjusts dosing, screens for side effects, and evaluates disease control.

Bottom line

Cosentyx works by blocking a single key inflammatory messenger, IL‑17A. In seniors, this reduces disease activity but also slightly lowers the body’s ability to fight off certain infections. With proper screening, monitoring, and supportive care, most older adults tolerate the drug well and enjoy a significant improvement in quality of life. Always discuss individual risks and benefits with your prescribing clinician.



Other Questions About Cosentyx :

How long until cosentyx showed improvement? Cosentyx patent expiration date in russia? Can cosentyx use impact vaccine protection? Cosentyx unoready list of alternative drugs? Are weight changes a common side effect of cosentyx? Is there a benefit to combining a vaccine with cosentyx? What is the typical cosentyx dose per injection for psoriatic arthritis?